In a report released yesterday, Jack Meehan from Barclays maintained a Hold rating on Syneos Health Inc (SYNH), with a price target of $48. The company’s shares closed yesterday at $48.48.
According to TipRanks.com, Meehan is a 4-star analyst with an average return of 6.9% and a 62.1% success rate. Meehan covers the Healthcare sector, focusing on stocks such as Bio-Rad Laboratories, PRA Health Sciences, and IQVIA Holdings Inc.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Syneos Health Inc with a $54.25 average price target.
See today’s analyst top recommended stocks >>
Based on Syneos Health Inc’s latest earnings release for the quarter ending December 31, the company reported a quarterly net profit of $45.67 million. In comparison, last year the company had a GAAP net loss of $24.55 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Syneos Health, Inc. engages in the provision of Morrisville. It operates though the Clinical Solutions and Commercial Solutions segments.
